Agenus (AGEN) EBT Margin Growth (1y) (2011 - 2026)
Powered by 
Analysis
Agenus (AGEN) EBT Margin Growth (1y) (2011 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.43 Bn | 130.58 Bn | 2.84 Bn | -153.00 |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -571.00 |
| 3 | Argenx Se | 63.34 Bn | 58.15 Bn | 1.37 Bn | 553.00 |
| 4 | Moderna | 57.98 Bn | 52.85 Bn | 52.00 Mn | 4,709.00 |
| 5 | Revolution Medicines | 43.98 Bn | 43.98 Bn | - | - |
| 6 | BeOne Medicines | 39.92 Bn | 34.82 Bn | 1.53 Bn | 1,076.00 |
| 7 | Alnylam Pharmaceuticals | 35.42 Bn | 32.11 Bn | 992.69 Mn | 1,911.00 |
| 8 | Royalty Pharma | 28.42 Bn | 27.58 Bn | - | -392.00 |
| 9 | Insmed | 27.36 Bn | 26.20 Bn | 358.27 Mn | 29,565.00 |
| 10 | Agenus | 341.87 Mn | 341.87 Mn | 34.52 Mn | 10,533.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 10,533.00 |
| Mar 31, 2026 | 10,962.00 |
| Dec 31, 2025 | 16,883.00 |
| Sep 30, 2025 | 20,914.00 |
| Jun 30, 2025 | 14,669.00 |
| Mar 31, 2025 | 11,415.00 |
| Dec 31, 2024 | -11,584.00 |
| Sep 30, 2024 | -50.00 |
| Jun 30, 2024 | 2,585.00 |
| Mar 31, 2024 | 8,709.00 |
| Dec 31, 2023 | 20,677.00 |
| Sep 30, 2023 | -1,581.00 |
| Jun 30, 2023 | -1,074.00 |
| Mar 31, 2023 | -11,443.00 |
| Dec 31, 2022 | 8,394.00 |
| Sep 30, 2022 | -31,900.00 |
| Jun 30, 2022 | 49,561.00 |
| Mar 31, 2022 | 29,333.00 |
| Dec 31, 2021 | -22,719.00 |
| Sep 30, 2021 | 41,142.00 |